Pharmacological Management of No Reflow During Percutaneous Coronary Intervention

Publisher： Bentham Science Publishers

E-ISSN： 1875-6212|4|2|95-100

ISSN： 1570-1611

Source： Current Vascular Pharmacology, Vol.4, Iss.2, 2006-04, pp. : 95-100

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Update in Pharmacological Management of Coronary No-Reflow Phenomenon

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 10, Iss. 3, 2012-01 ,pp. : 256-264

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacological Approach of No-Reflow Phenomenon Related with Percutaneous Coronary Interventions

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 6, Iss. 2, 2008-04 ,pp. : 125-129

Bentham Science Publishers

Access to resources Recommend Favorite

The no-reflow phenomenon associated with percutaneous coronary intervention: its mechanisms and treatment

By Ito Hiroshi  

Cardiovascular Intervention and Therapeutics, Vol. 26, Iss. 1, 2011-01 ,pp. : 2-11

Springer Publishing Company

Access to resources Recommend Favorite

Primary percutaneous coronary intervention: devices to prevent no-reflow phenomenon

By Weitsman Tatyana   Meerkin David  

Interventional Cardiology, Vol. 5, Iss. 3, 2013-06 ,pp. : 289-300

Future Medicine

Access to resources Recommend Favorite

Pharmacological Prevention of Peri-, and Post-Procedural Myocardial Injury in Percutaneous Coronary Intervention

By  

Current Cardiology Reviews, Vol. 4, Iss. 3, 2008-08 ,pp. : 223-230

Bentham Science Publishers

Access to resources Recommend Favorite